Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE

Area of Science:

• Immunology
• Pulmonology
• Regenerative Medicine

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
• SLE can manifest with diverse organ involvement, including the lungs.
• Diffuse alveolar hemorrhage (DAH) is a rare but severe pulmonary complication of SLE.

Observation:

• A 19-year-old female with SLE developed acute DAH.
• Symptoms included hemoptysis, dyspnea, hypoxemia, and diffuse alveolar infiltrates on CT.
• The patient's condition was refractory to high-dose corticosteroids and intravenous immunoglobulin therapy.

Findings:

• Diagnosis of DAH in SLE was confirmed through clinical and radiological findings.
• Standard immunosuppressive treatments failed to improve the patient's severe respiratory compromise.
• Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells was performed.

Implications:

• Mesenchymal stem cell transplantation offers a potential therapeutic option for severe, refractory DAH in SLE.
• This case highlights the efficacy of regenerative medicine in managing life-threatening autoimmune complications.
• Further research is warranted to explore the role of stem cell therapy in SLE management.